Capula Management’s Guardant Health GH Stock Holding History

Capula Management’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-28,140	Closed	-$834K	–	392
2023 Q3	$834K	Buy	+28,140	New	+$990K	0.02%	260

Other funds holding GH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Capula Management's GH Position: Q4 2023 in Review

Capula Management sold out of Guardant Health (GH) in Q4 2023, closing a stake of 28,140 shares — an estimated $834K sold.

Capula Management first reported a position in GH in Q3 2023 and held it in 1 quarter. The position peaked at $834K in Q3 2023. 294 funds tracked by Wall St. Rank hold GH as of Q4 2023.

Capula Management reported no remaining Guardant Health position as of Q4 2023 after selling out during the quarter.
Capula Management sold 28,140 Guardant Health shares in Q4 2023, an estimated $834K.
Capula Management first reported a position in Guardant Health in Q3 2023 and held it in 1 quarter.
Capula Management's Guardant Health position peaked at $834K in Q3 2023.
294 funds tracked by Wall St. Rank held Guardant Health as of Q4 2023.

Based on Capula Management's 13F filing for Q4 2023, filed 12 Feb 2024.